Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-17-002057
Filing Date
2017-04-13
Accepted
2017-04-13 14:45:04
Documents
1
Period of Report
2017-04-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT slakter-form4_041017.html 4  
1 OWNERSHIP DOCUMENT slakter-form4_041017.xml 4 7734
  Complete submission text file 0001387131-17-002057.txt   9291
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 57 MEADOW WOODS ROAD GREAT NECK NY 11020
Business Address
Slakter Jason Scott (Reporting) CIK: 0001630109 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 17760354